Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco
Abstract Background Few epidemiological studies on primary cutaneous lymphomas are available and related to limited populations. Objectives To characterize the epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas from a global perspective at the national level. Methods A c...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | JEADV Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jvc2.264 |
| _version_ | 1797289321694232576 |
|---|---|
| author | Fouzia Hali Salma Zakaryaa Karima Senouci Zineb Zeggwagh Fatima Zahra Mernissi Sara Elloudi Fatima Zahra Hashas Said Amal Ouafa Hocar Maryem Aboudourib Awatef Kelati Inas Chikhaoui Asmaa Quessar Soumiya Chiheb |
| author_facet | Fouzia Hali Salma Zakaryaa Karima Senouci Zineb Zeggwagh Fatima Zahra Mernissi Sara Elloudi Fatima Zahra Hashas Said Amal Ouafa Hocar Maryem Aboudourib Awatef Kelati Inas Chikhaoui Asmaa Quessar Soumiya Chiheb |
| author_sort | Fouzia Hali |
| collection | DOAJ |
| description | Abstract Background Few epidemiological studies on primary cutaneous lymphomas are available and related to limited populations. Objectives To characterize the epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas from a global perspective at the national level. Methods A cross‐sectional descriptive multicenter study including patients treated for cutaneous lymphomas at dermatology and venereology departments of different university hospitals in the kingdom of Morocco from January 2012 to December 2021. Results Our multicenter cohort consisted of 402 patients. The median age was 56 years (15–114) with a male predominance (61%, 245 cases). Based on the WHO‐EORTC classification, the most frequent histological type was cutaneous T‐cell lymphoma (CTCL) (88% of cases). Of these, mycosis fungoides (MF) was the most common (78%). B‐cell lymphomas represented 12% of cases, mainly centro‐follicular B‐cell lymphoma (40%). The clinical presentation was most frequently erythematous and scaly infiltrated lesions in 187 CTCL patients (52.6%), and nodular lesions in 37 patients (78%) with B‐cell lymphomas. Treatment modalities depended on the tumour's histological type and stage and included: topical corticosteroids and phototherapy in 52% of cases, monochemotherapy, radiotherapy, photopheresis and polychemotherapy. The evolution was marked by remission in 41% of patients, relapse in 17% and death in 12%. Conclusions Our national study provides data on primary cutaneous lymphomas in Morocco, never before mentioned in indexed literature. We identified 402 cases over a 10‐year period. A better knowledge of these entities is key to optimize diagnosis and therapy. |
| first_indexed | 2024-03-07T19:02:18Z |
| format | Article |
| id | doaj.art-50516d98b2994bdcaa41cf10496887cd |
| institution | Directory Open Access Journal |
| issn | 2768-6566 |
| language | English |
| last_indexed | 2024-03-07T19:02:18Z |
| publishDate | 2024-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | JEADV Clinical Practice |
| spelling | doaj.art-50516d98b2994bdcaa41cf10496887cd2024-03-01T11:39:22ZengWileyJEADV Clinical Practice2768-65662024-03-013120921310.1002/jvc2.264Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in MoroccoFouzia Hali0Salma Zakaryaa1Karima Senouci2Zineb Zeggwagh3Fatima Zahra Mernissi4Sara Elloudi5Fatima Zahra Hashas6Said Amal7Ouafa Hocar8Maryem Aboudourib9Awatef Kelati10Inas Chikhaoui11Asmaa Quessar12Soumiya Chiheb13Department of Dermatology and Venereology Ibn Rochd University Hospital Casablanca MoroccoDepartment of Dermatology and Venereology Ibn Rochd University Hospital Casablanca MoroccoDepartment of Dermatology and Venereology Ibn Sina University Hospital Rabat MoroccoDepartment of Dermatology and Venereology Ibn Sina University Hospital Rabat MoroccoDermatology and Venereology Department Hassan II University Hospital Fez MoroccoDermatology and Venereology Department Hassan II University Hospital Fez MoroccoDermatology and Venereology Department Hassan II University Hospital Fez MoroccoDepartment of Dermatology and Venereology Mohamed VI University Hospital Marrakech MoroccoDepartment of Dermatology and Venereology Mohamed VI University Hospital Marrakech MoroccoDepartment of Dermatology and Venereology Mohamed VI University Hospital Marrakech MoroccoDepartment of Dermatology and Venereology Cheikh Khalifa University Hospital Casablanca MoroccoDepartment of Dermatology and Venereology Cheikh Khalifa University Hospital Casablanca MoroccoDepartment of Haematology and Paediatric Oncology 20 Aout Hospital Casablanca MoroccoDepartment of Dermatology and Venereology Ibn Rochd University Hospital Casablanca MoroccoAbstract Background Few epidemiological studies on primary cutaneous lymphomas are available and related to limited populations. Objectives To characterize the epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas from a global perspective at the national level. Methods A cross‐sectional descriptive multicenter study including patients treated for cutaneous lymphomas at dermatology and venereology departments of different university hospitals in the kingdom of Morocco from January 2012 to December 2021. Results Our multicenter cohort consisted of 402 patients. The median age was 56 years (15–114) with a male predominance (61%, 245 cases). Based on the WHO‐EORTC classification, the most frequent histological type was cutaneous T‐cell lymphoma (CTCL) (88% of cases). Of these, mycosis fungoides (MF) was the most common (78%). B‐cell lymphomas represented 12% of cases, mainly centro‐follicular B‐cell lymphoma (40%). The clinical presentation was most frequently erythematous and scaly infiltrated lesions in 187 CTCL patients (52.6%), and nodular lesions in 37 patients (78%) with B‐cell lymphomas. Treatment modalities depended on the tumour's histological type and stage and included: topical corticosteroids and phototherapy in 52% of cases, monochemotherapy, radiotherapy, photopheresis and polychemotherapy. The evolution was marked by remission in 41% of patients, relapse in 17% and death in 12%. Conclusions Our national study provides data on primary cutaneous lymphomas in Morocco, never before mentioned in indexed literature. We identified 402 cases over a 10‐year period. A better knowledge of these entities is key to optimize diagnosis and therapy.https://doi.org/10.1002/jvc2.264clinicalcutaneousepidemiologicprimary lymphomastherapeutic |
| spellingShingle | Fouzia Hali Salma Zakaryaa Karima Senouci Zineb Zeggwagh Fatima Zahra Mernissi Sara Elloudi Fatima Zahra Hashas Said Amal Ouafa Hocar Maryem Aboudourib Awatef Kelati Inas Chikhaoui Asmaa Quessar Soumiya Chiheb Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco JEADV Clinical Practice clinical cutaneous epidemiologic primary lymphomas therapeutic |
| title | Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco |
| title_full | Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco |
| title_fullStr | Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco |
| title_full_unstemmed | Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco |
| title_short | Epidemiologic, clinical and therapeutic features of primary cutaneous lymphomas in Morocco |
| title_sort | epidemiologic clinical and therapeutic features of primary cutaneous lymphomas in morocco |
| topic | clinical cutaneous epidemiologic primary lymphomas therapeutic |
| url | https://doi.org/10.1002/jvc2.264 |
| work_keys_str_mv | AT fouziahali epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT salmazakaryaa epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT karimasenouci epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT zinebzeggwagh epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT fatimazahramernissi epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT saraelloudi epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT fatimazahrahashas epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT saidamal epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT ouafahocar epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT maryemaboudourib epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT awatefkelati epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT inaschikhaoui epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT asmaaquessar epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco AT soumiyachiheb epidemiologicclinicalandtherapeuticfeaturesofprimarycutaneouslymphomasinmorocco |